Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Biostar Pharma Announces First Patient Enrolled for Phase 1 Study of Utidelone Capsule (UTD2)--The World's First Oral Epothilone Anti-Cancer Drug
Biostar Pharma, the US subsidiary of Beijing Biostar Pharmaceuticals which is a synthetic biology-driven biopharma […]
Axol Bioscience Collaborates with StrataStem to Deliver Stem Cell-Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease
Axol Bioscience, a leading pluripotent stem cell technology provider for drug discovery has signed an […]
ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery
ClearPoint Neuro, a global therapy-enabling platform company providing navigation and delivery to the brain, today […]
CHARM Therapeutics Receives Investment for Deep Learning-Enabled Drug Discovery Research from NVIDIA
CHARM Therapeutics, a 3D deep-learning biotechnology company discovering and developing transformational medicines, today announced an […]
Areteia Therapeutics Announces Appointment of Elyse Stock, M.D. To Board of Directors
Areteia Therapeutics, today announced the appointment of Elyse Stock to the Areteia Board of Directors, […]
Merck & XtalPi Collaboration Optimizes Drug Formulations with AI-Powered Techniques
Science and technology company Merck and XtalPi, a pioneering pharmaceutical technology company powered by artificial […]
Kurve Therapeutics Announces Development of New Intellectual Property to Target Drug Delivery in the Brain
Today, Kurve Therapeutics announced it has filed for new intellectual property on its nose to […]
C4XD and Garvan Institute of Medical Research Report Successful Patient Stratification Approach Using C4XD's New Precision Medicine Platform PatientSeek
C4X Discovery Holdings (C4XD), a pioneering Drug Discovery company, announces the launch of a precision […]
Jnana Therapeutics Announces FDA Clearance of IND Application for JNT-517 for the Treatment of Phenylketonuria
Jnana Therapeutics, a biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug […]
Sustained Therapeutics Advancing Clinical Trial for Novel Drug Delivery Platform
A Vancouver-based therapeutics company, Sustained Therapeutics, has received regulatory approval to begin the second Phase […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more